IBSRELA
NDC 73154-050, tenapanor hydrochloride, tablet, from Ardelyx, Inc..
- Product NDC
- 73154-050
- Status
- Listed
- Labeler
- Ardelyx, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211801
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73154-050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TENAPANOR HYDROCHLORIDE53.2 mg/1
Pharmacologic classes
Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]; Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]; Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73154-050-06 | 73154005006 | 6 TABLET in 1 BOTTLE (73154-050-06) |
| 73154-050-60 | 73154005060 | 60 TABLET in 1 BOTTLE (73154-050-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2102da5f-a1a0-4ac7-a1f6-38698cf7273aNADAC price for package 73154005060
GET /v1/drugs/nadac/73154005060
Use it
Look up 73154-050 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73154-050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73154-050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.